MCQ: Complication of Surfactant therapy

Clinical Scenario:

A 31-week male infant weighing 1.45 kg develops progressive respiratory distress within the first hour of life. He is managed with nasal CPAP. At 12 hours of age, his oxygen requirement has increased from FiO₂ 0.25 to 0.45 despite CPAP of 7 cm H₂O.

Arterial blood gas shows:

  • pH 7.26
  • PaCO₂ 60 mmHg
  • PaO₂ 52 mmHg

Chest radiograph demonstrates symmetrical diffuse reticulogranular infiltrates with air bronchograms.

Surfactant is administered, resulting in rapid improvement.

Two hours later, the infant suddenly deteriorates with severe desaturation and bradycardia. Examination reveals markedly reduced breath sounds over the right hemithorax, and the heart sounds are displaced to the left.

Which of the following is the most likely diagnosis?

A. Massive pulmonary hemorrhage
B. Patent ductus arteriosus
C. Right-sided tension pneumothorax
D. Severe intraventricular hemorrhage
E. Worsening respiratory distress syndrome

Correct Answer

C. Right-sided tension pneumothorax

Explanation: Complication of Surfactant therapy 

This infant initially has classical surfactant-deficient RDS.

The key to the question is the sudden deterioration after initial improvement.

Features suggesting tension pneumothorax include:

  • Sudden hypoxemia
  • Bradycardia
  • Abrupt deterioration
  • Unilateral reduction in breath sounds
  • Mediastinal shift

Premature infants with RDS receiving CPAP or positive-pressure ventilation are at increased risk of air-leak syndromes, especially after surfactant when lung compliance changes rapidly.

Immediate needle thoracocentesis should be performed without waiting for radiographic confirmation if the infant is unstable.

Why the other options are incorrect

A. Massive pulmonary hemorrhage

  • Usually presents with bloody secretions from the endotracheal tube and diffuse bilateral deterioration.

B. Patent ductus arteriosus

  • Causes gradual worsening over days rather than sudden unilateral findings.

D. Severe intraventricular hemorrhage

  • Causes neurological deterioration but does not produce unilateral absent breath sounds or mediastinal shift.

E. Worsening respiratory distress syndrome

RDS deteriorates progressively, not with sudden unilateral chest findings.

Pearl

The most dangerous complication of surfactant in a ventilated preterm infant with RDS is an air-leak syndrome.

Sudden deterioration with:

  • ↓ unilateral air entry
  • Bradycardia
  • Desaturation
  • Mediastinal shift

should be treated as tension pneumothorax until proven otherwise.

Find high yield pediatric board exam MCQs System wise for MRCPCH, FCPS , MD APB & MCCQ .

External Resources

    1. Merck Manual Professional Edition: Pulmonary Air-Leak Syndromes in Neonates – Clinical features, diagnosis, and emergency management of neonatal pneumothorax.

    2. European Consensus Guidelines on the Management of Respiratory Distress Syndrome – Evidence-based guidance on surfactant therapy, respiratory support, and complications in preterm infants.

    3. European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2025 Update – Updated recommendations for respiratory support and surfactant administration in preterm neonates.

References

  1. Sweet DG, Carnielli V, Greisen G, Hallman M, Klebermass-Schrehof K, Ozek E, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update. Neonatology. 2023;120(1):3-23. doi: 10.1159/000528914.

  2. Merck Manual Professional Edition. Pulmonary air-leak syndromes in neonates [Internet]. Available from: https://www.merckmanuals.com/professional/pediatrics/respiratory-problems-in-neonates/pulmonary-air-leak-syndromes.

Scroll to Top